首页|基于miR-135a/FOXO1/PINK1通路探讨柔肝化纤颗粒调控线粒体自噬抑制肝星状细胞活化的机制

基于miR-135a/FOXO1/PINK1通路探讨柔肝化纤颗粒调控线粒体自噬抑制肝星状细胞活化的机制

扫码查看
目的 基于miR-135a/FOXO1/PINK1通路探讨柔肝化纤颗粒通过调控线粒体自噬来抑制肝星状细胞活化与增殖的影响及其机制。方法 HSC-T6分为空白组、H2O2组、miR-135a-NC组、miR-135a-mimic组、miR-135a-in-hibitor-NC+H2O2组、miR-135a-inhibitor+H2O2组、柔肝化纤颗粒含药血清对照组、H2O2+含药血清对照组、H2O2+含药血清组、H2O2+含药血清+miR-135a-NC组及H2O2+含药血清+miR-135a-mimic组。分别采用Real-time PCR、Western Blot、ELISA 及流式细胞术检测 miR-135a、FOXO1、PINK1、Parkin、LC3 Ⅱ、Smad2、p-Smad2、转化生长因子-β1(transforming growth factor beta 1,TGF-β1)、NF-κB p65、p-NF-κB p65、α-SMA、Ⅰ 型胶原、Ⅲ型胶原、TNF-α表达及线粒体膜电位、活性氧(reactive oxygen species,ROS)生成。结果 给予H2O2及过表达miR-135a可显著上调HSC-T6 miR-135a、α-SMA、Ⅰ 型胶原、Ⅲ 型胶原、p-Smad2、TGF-β1、p-NF-κB p65、TNF-α 表达及 ROS 生成(P<0。01);下调FOXO1、PINK1、Parkin、LC3 Ⅱ表达与线粒体膜电位(P<0。01)。给予柔肝化纤颗粒及抑制miR-135a表达可显著下调 HSC-T6 miR-135a、α-SMA、Ⅰ 型胶原、Ⅲ 型胶原、p-Smad2、TGF-β1、p-NF-κB p65、TNF-α 表达及ROS生成(P<0。01);上调FOXO1、PINK1、Parkin、LC3 Ⅱ表达与线粒体膜电位(P<0。01)。给予柔肝化纤颗粒同时过表达miR-135a可抑制柔肝化纤颗粒对HSC-T6的影响(P<0。01)。结论 线粒体自噬可抑制HSC-T6活化,其机制与线粒体自噬抑制ROS生成,进而抑制TGF-β1/Smad2通路及炎症反应有关;柔肝化纤颗粒亦可抑制HSC-T6活化,其机制与柔肝化纤颗粒抑制miR-135a表达,活化FOXO1/PINK1通路,从而促进线粒体自噬有关。
Exploring Mechanism of Regulating Mitochondrial Autophagy and Inhibiting Hepatic Stellate Cell Activation by Ruangan Huaxian Granules(柔肝化纤颗粒)Based on miR-135a/FOXO1/PINK1 Pathway
Objective Based on miR-135a/FOXO1/PINK1 pathway,the effect and mechanism of Ruangan Huaxian Granules(柔 肝 化纤颗粒)on inhibiting activation and proliferation of hepatic stellate cells by regulating mitochondrial autophagy.Meth-ods HSC-T6 was divided into blank group,H2O2 group,miR-135a-NC group,miR-135a-mimic group,miR-135a inhibi-tor NC+H2O2 group,miR-135a-inhibitor+H2O2 group,drug-containing serum(Ruangan Huaxian Granules)control group,H2O2+drug-containing serum control group,H2O2+drug containing serum group,H2O2+drug-containing serum+miR-135a-NC group and H2O2+drug-containing serum+miR-135a-mimic group.The expressions of MiR-135a,recombinant forkhead box protein O1(FOXO1),PTEN induced putative kinase 1(PINK1),Parkin,human microtubule-associated protein light chain 3 Ⅱ(LC3 Ⅱ),Smad2,p-Smad2 and transforming growth factor beta 1(TGF-β1),nuclear factor kappa-B(NF-KB)p65,p-NF-κB p65,α-smooth muscle actin(α-SMA),type Ⅰ collagen,type Ⅲ collagen and tumor necrosis factor-α(TNF-α),mitochondrial membrane potential and reactive oxygen species(ROS)production were detected by Real time PCR,Western Blot,ELISA and flow cytometry,respectively.Results Administration of H2O2 and over-expression of miR-135a sig-nificantly up-regulated the expressions of HSC-T6 miR-135a,α-SMA,type Ⅰ collagen,type Ⅲ collagen,p-Smad2,TGF-β1,p-NF-κB p65,TNF-α and ROS production(P<0.01),down-regulate the expressions of FOXO1,PINK1,Parkin and LC3 Ⅱ and mitochondrial membrane potential(P<0.01).Administration of Ruogan Huaxian Granules and inhibition of miR-135a expression can significantly down-regulate the expressions of HSC-T6 miR-135a,α-SMA,type 1 collagen,type Ⅲcollagen,p-Smad2,TGF-β1,p-NF κB p65 and TNF-α and ROS production(P<0.01),up-regulate the expressions of FOXO1,PINK1,Parkin and LC3 Ⅱ and mitochondrial membrane potential(P<0.01).Simultaneous over-expression of miR-135a with Ruogan Huaxian Granules can inhibit the effect of Ruogan Huaxian Granules on HSC-T6(P<0.01).Conclusions-Mitochondrial autophagy can inhibit HSC-T6 activation,and its mechanism is related to the inhibition of ROS production by mi-tochondrial autophagy,which in turn inhibits TGF-β1/Smad2 pathway and inflammatory response.Rougan Huaxian Granules can also inhibit the activation of HSC-T6,and its mechanism is related to the inhibition of miR-135a expression by Ruogan Huaxian Granules,activation of the FOXO1/PINK1 pathway and promotion of mitochondrial autophagy.

mitochondrial autophagyHSC-T6Rougan Huaxian Granules(柔肝化纤颗粒)miR-135aFOXO1

张文富、吴姗姗、戴铭、吕建林、黄晶晶、李晓龙、王振常

展开 >

广西中医药大学第一附属医院,广西南宁 530023

广西国际壮医医院,广西南宁 530201

广西中医药大学基础医学院,广西南宁 530299

广西中医基础研究重点实验室,广西南宁 530299

广西高发传染病中西医结合转化医学重点实验室,广西南宁 530299

广西医科大学基础医学院,广西南宁 530021

展开 >

线粒体自噬 HSC-T6 柔肝化纤颗粒 miR-135a FOXO1

国家自然科学基金项目国家自然科学基金项目广西自然科学基金项目广西自然科学基金项目戴铭广西名中医工作室建设项目

81960910818608392020GXNSFDA2970212020GXNSFAA2380202023017-05-09

2024

中华中医药学刊
中华中医药学会 ,辽宁中医药大学

中华中医药学刊

CSTPCD北大核心
影响因子:1.007
ISSN:1673-7717
年,卷(期):2024.42(4)
  • 27